Thomas Boesen — Management
Roles
03.03.2026 – 03.03.2026
Transactions (including via associated entities)
| Date | Issuer | Nature | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 03.03.2026 | SynAct Pharma AB Stockholm | Bought — open marketAcquisition via Boesen Biotech ApS | 2,750 | SEK 17.92 | SEK 49,280.00 | ↗ |
| 03.03.2026 | SynAct Pharma AB Stockholm | Bought — open marketAcquisition via Boesen Biotech ApS | 2,700 | SEK 17.90 | SEK 48,330.00 | ↗ |